Hepta Bio
PrivateLast Round
Seed
Nov 5, 2025
Total Funding Raised
$6.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hepta Bio is a biotechnology company that develops a liquid biopsy and AI platform to read the cell-free DNA epigenome and detect organ-specific signals of chronic disease, with an initial focus on metabolic dysfunction-associated steatohepatitis (MASH).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hepta Bio Comparables
Compare Hepta Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AGED Diagnostics | 89% | |
| Glycotest, Inc. | 75% | |
| Senseera | 71% |
Hepta Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 5, 2025 |
Key People
Founding team and executive leadership
Hepta Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SeaX Ventures | Seed |
| AME Cloud Ventures | Seed |
| Alumni Ventures | Seed |
| Felicis Ventures | Seed |
| Illumina Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 24, 2026
Grew 100% QoQ from 3 to 6 employees.
- Apr 19, 2026
Monthly visitors increased 35% MoM, reaching 2.8K.
Hepta Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hepta Bio's valuation, stock price, and market status.
Is Hepta Bio a public or private company?
Hepta Bio is a private company.
What is the current stock price of Hepta Bio?
Hepta Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Hepta Bio worth (valuation)?
Valuation information for Hepta Bio is not publicly available.
Can I buy Hepta Bio stock?
Hepta Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hepta Bio's last funding round?
Hepta Bio's most recent funding round was Seed on November 5, 2025.
Who are the main investors in Hepta Bio?
Key investors in Hepta Bio include Felicis Ventures, Illumina Ventures.
Will Hepta Bio IPO soon?
No public IPO plans have been announced for Hepta Bio.
How can I track Hepta Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hepta Bio's secondary market activity and sign up for updates.